“Growing Demand Driven by Procedural Precision and Minimally Invasive Interventions”
- A significant and accelerating trend in the global atherectomy and intravascular lithotripsy (IVL) devices market is the increasing demand for precision-guided, minimally invasive vascular interventions aimed at treating complex calcified arterial lesions
- For instance, Shockwave Medical Inc. has expanded its intravascular lithotripsy technology portfolio to treat severe arterial calcification in both coronary and peripheral arteries. The company’s IVL catheter systems utilize sonic pressure waves to fracture calcium deposits with minimal trauma to surrounding soft tissue, a key benefit for patients with fragile vasculature or comorbidities
- The rise of image-guided atherectomy systems, such as those offered by Boston Scientific and Cardiovascular Systems Inc., supports procedural safety and improved clinical outcomes. These systems are becoming increasingly favored for complex cases, including in-stent restenosis and long chronic total occlusions (CTOs)
- Atherectomy systems now offer greater lesion modification capabilities with a lower risk of vessel dissection or perforation compared to traditional balloon angioplasty, making them the preferred choice in PAD and CAD cases with significant calcification
- Technological advancements, including the integration of real-time feedback, improved catheter designs, and physician-friendly console interfaces, are boosting adoption across both hospitals and outpatient settings
- The demand for Atherectomy and IVL devices is growing rapidly across North America, Europe, and Asia-Pacific, as interventional cardiologists and vascular surgeons increasingly prioritize tools that reduce procedural complexity while enhancing patient outcomes. The trend toward outpatient-based interventions and value-based care further fuels the market’s expansion
